Portopulmonary Hypertension Treated by Occlusion of a Spontaneous Portosystemic Shunt Followed by Endothelin Receptor Antagonist Administration

被引：1
|
作者：
Ishikawa, Tsuyoshi [1 ]
Kawamoto, Daiki [1 ]
Nishimura, Tatsuro [1 ]
Suetomi, Takeshi [2 ]
Kobayashi, Shigeki [3 ]
Takami, Taro [1 ]
机构：
[1] Yamaguchi Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, 1-1-1 Minami Kogushi, Ube, Yamaguchi 7558505, Japan
[2] Yamaguchi Univ, Grad Sch Med, Dept Med & Clin Sci, Ube, Yamaguchi, Japan
[3] Yamaguchi Univ, Sch Med, Dept Therapeut Sci Heart Failure Elderly, Ube, Yamaguchi, Japan
来源：
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY | 2024年 / 35卷 / 02期
关键词：
D O I：
10.1016/j.jvir.2023.10.028
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：313 / 315
页数：3
相关论文
共 50 条
  • [41] Hemodynamic effects of bosentan, an endothelin receptor antagonist, in patients with pulmonary hypertension
    Williamson, DJ
    Wallman, LL
    Jones, R
    Keogh, AM
    Scroope, F
    Penny, R
    Weber, C
    Macdonald, PS
    CIRCULATION, 2000, 102 (04) : 411 - 418
  • [42] Optimizing endothelin receptor antagonist use in the management of pulmonary arterial hypertension
    Steiner, M. Kathryn
    Preston, Ioana R.
    VASCULAR HEALTH AND RISK MANAGEMENT, 2008, 4 (05) : 943 - 952
  • [43] Sitaxsentan: an endothelin-A receptor antagonist for the treatment of pulmonary arterial hypertension
    O'Callaghan, DS
    Gaine, SP
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2006, 60 (04) : 475 - 481
  • [44] Treatment of pulmonary arterial hypertension with macitentan, dual endothelin receptor antagonist
    Bichara, Valentina M.
    Bevacqua, Raul J.
    INSUFICIENCIA CARDIACA, 2019, 14 (03) : 119 - 128
  • [45] Approaches to therapy for puhnonary hypertension: Role of the endothelin receptor antagonist bosentan
    Avdeev, S. N.
    TERAPEVTICHESKII ARKHIV, 2015, 87 (09) : 64 - 71
  • [46] Secondary pulmonary arterial hypertension treated with endothelin receptor blockade
    Sharma, S
    Kashour, T
    Philipp, R
    TEXAS HEART INSTITUTE JOURNAL, 2005, 32 (03) : 405 - 410
  • [47] A spontaneous portosystemic shunt from the left gastric vein to the left renal vein caused by portal hypertension
    Dick, E
    Watkinson, A
    AMERICAN JOURNAL OF ROENTGENOLOGY, 1999, 173 (02) : 502 - 503
  • [48] Liver Stiffness Measured By Transient Elastography Is Predictive of the Prognosis Following Portosystemic Shunt Occlusion in Patients with Portal Hypertension
    Ishikawa, Tsuyoshi
    Sasaki, Ryo
    Nishimura, Tatsuro
    Iwamoto, Takuya
    Takami, Taro
    Sakaida, Isao
    HEPATOLOGY, 2018, 68 : 487A - 487A
  • [49] Aprocitentan, A Dual Endothelin Receptor Antagonist Under Development for the Treatment of Resistant Hypertension
    Angeli, Fabio
    Verdecchia, Paolo
    Reboldi, Gianpaolo
    CARDIOLOGY AND THERAPY, 2021, 10 (02) : 397 - 406
  • [50] Aprocitentan Dual endothelin ETA/ETB receptor antagonist Treatment of resistant hypertension
    Warden, B. A.
    Duell, P. B.
    DRUGS OF THE FUTURE, 2021, 46 (08) : 595 - 611
12345